Navigation Links
Ireland Cancer Center researchers advance stem cell gene therapy
Date:12/12/2007

Ireland Cancer Center of University Hospitals Case Medical Center researchers have recently made great strides in stem cell gene therapy research by transferring a new gene to cancer patients, via their own stem cells, with the ultimate goal of being able to use stronger chemotherapy treatment with less severe side effects. Under this protocol, MGMT, a drug-resistance gene, is added into purified hematopoietic stem cells to protect these cells from the damage of chemotherapy regimens.

In one of 24 presentations by Ireland Cancer Center researchers at the annual American Society of Hematology meeting, Stanton Gerson, MD, and colleagues presented that eight patients were enrolled on the trial and six were infused with their own stem cells which were engineered to carry the MGMT gene. In three patients, stem cells carrying the gene were identified in their blood or bone marrow. In one patient, stem cells carrying the gene were detected up to 28 weeks after their administration. This significant finding has never been reported before with this gene and drug combination.

This study is the first to show the success of treatment with evidence that stem cells now carry the new gene, says Dr. Gerson, Director of the Ireland Cancer Center and Case Comprehensive Cancer Center, who spearheaded the Phase I study along with a team of researchers. These patients show the success of treatment with evidence that their stem cells now carry the new genes. This is a breakthrough V the first time selection with MGMT has been shown to occur in patients.

Preclinical animal research, conducted by Dr. Gerson and his colleagues, has shown that the gene G156A-MGMT can provide stem cells with very high levels of drug resistance, compared to normal stem cells not carrying the gene. In the Phase I trial for patients with advanced malignancies, researchers collected peripheral blood stem cells from patients and exposed them to a retrovirus containing the G156
'/>"/>

Contact: Alicia Reale
alicia.reale@uhhospitals.org
216-844-5158
University Hospitals of Cleveland
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
2. A study by the MUHC and McGill University opens a new door to understanding cancer
3. ESF EURYI award winner aims to stop cancer cells reading their own DNA
4. Protein chatter linked to cancer activation
5. Newly created cancer stem cells could aid breast cancer research
6. Western diet linked to increased risk of colon cancer recurrence
7. Obesity and lack of exercise could enhance the risk of pancreatic cancer
8. Low levels of key protein may indicate pancreatic cancer risk
9. Birth records hold pancreatic cancer clue
10. Many parents at-risk for cancer disclose genetic test results to children
11. A new radiation therapy treatment developed for head and neck cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...alian researchers and a pathology company have joi...system which may reveal a way to predict premature...Melbourne, the University of Newcastle and Symbion...earch, engineering and pathology to develop a comp...ure birth., About 17,000 pre-term births occur in...
(Date:9/4/2008)...s press release is available in German . , Cyst...arcinoma: Many diseases of the excretory organs ar...ary absence of characteristic proteins in the ren... leadership of scientists from DKFZ and Heidelberg...model to better investigate these conditions. , ...
(Date:9/4/2008)...IDENCE New research from Rhode Island Hospital fo...M) can contribute to mild neurodegeneration with f...first study to show that obesity can cause neurode...Alzheimer,s Disease Volume 15:1 (September 2008) ...r Suzanne de la Monte, MD, MPH, of Rhode Island Ho...
(Date:9/3/2008)...ladelphia, PA September 4, 2008) The tumor suppre...ent prognostic biomarker in cases of soft tissue s...oration of researchers, including scientists at th...ar Medicine at the College of Science and Technolo...epartment of Human Pathology and Oncology, Univers...
Breaking Biology News(10 mins):World-first to predict premature births 2Gaining a better understanding of kidney diseases 2International team reveals first prognosticator of survival in aggressive cancer 2Religious Leaders Join The Balm In Gilead to Support The Big Coffee Project to Help Fight HIV AIDS in the United States and in Africa 13642 1Religious Leaders Join The Balm In Gilead to Support The Big Coffee Project to Help Fight HIV AIDS in the United States and in Africa 13642 2Religious Leaders Join The Balm In Gilead to Support The Big Coffee Project to Help Fight HIV AIDS in the United States and in Africa 13642 3Religious Leaders Join The Balm In Gilead to Support The Big Coffee Project to Help Fight HIV AIDS in the United States and in Africa 13642 4Lupus Foundation of America Webchat to Discuss Kidney Disease in Lupus 13640 1Lupus Foundation of America Webchat to Discuss Kidney Disease in Lupus 13640 2Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 1Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 2Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 3Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 4Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 5Medline and 3M Agree to Strategic Partnership in Electrosurgery 3758 1Medline and 3M Agree to Strategic Partnership in Electrosurgery 3758 2Medline and 3M Agree to Strategic Partnership in Electrosurgery 3758 3
... believing, especially in medicine. From magnetic ...) scan, images of the body’s tissues and organs ha...nose disease and make recommendations for effectiv...nology developed at Kent State University will pro...to evaluate medical images that are commonly used....
...s ability to replace the tissue it sloughs off is ... Harvard Medical School published in the May 4 iss...r" of this regeneration process not only for skin,... prostate, and urogenital tract. This master regul...p63 gene, a close relative to the well-known tumor...
...y of Manchester researchers are ridding diabetic p...oot ulcers with maggots. , Professor Andrew Boulto...at 13 diabetic patients whose foot ulcers were con...ed within a mean period of three weeks, much quick...treatment. , Professor Boulton, who published t...
... clinical trial to test a revolutionary treatment ...searchers at UCL (University College London). The ...first of its kind and could have a significant imp...trial involves adults and children who have a cond...hich is a type of inherited retinal degeneration. ...
Other Biology News:Novel system developed to turn data into real-time, interactive 3-D images 2Master regulatory gene of epithelial stem cells identified 2Maggots rid patients of MRSA 2First clinical trial of gene therapy for childhood blindness 2
(Date:9/3/2008).../- Wyeth (NYSE: WYE ),toda... 54, to Vice,President, Corporate Communications. ...t, Corporate Affairs, Mr. McIntyre will be respons...for the corporation and its three,major divisions ...l health,-- around the world., Prior to joining W...
(Date:9/3/2008)...eeting to be held September 24 to 26 in Kansas Cit...) September 3, 2008 -— The U.S. Pharmacopeia...Meeting (ASM) will be held in Kansas City, Mo., Se... interact with the USP experts responsible for est... prescription and over-the-counter medicines, food...
(Date:9/3/2008).... 3 /- ESA Biosciences, a Magellan,Bi...on systems that improve,results for pharmaceutical...al-chemistry customers worldwide, announced that i...rican Technology Innovation Award in the,field of ...will present the,award to ESA,s Vice President of ...
(Date:9/3/2008)...swire/ -- US Oncology Specialty, LP, the,state-of-...ncology, has,received the Occupational Excellence ... for its outstanding safety achievements., The aw...t of the best",in safety and safety performance. T... from work resulting from workplace injuries or il...
Breaking Biology Technology:Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications 2USP's 2008 Annual Scientific Meeting to Convene Scientific Experts from Around the World 2USP's 2008 Annual Scientific Meeting to Convene Scientific Experts from Around the World 3ESA Receives 2008 Frost & Sullivan North American Technology Innovation Award for Development of Integrated Metabolomics Systems 2ESA Receives 2008 Frost & Sullivan North American Technology Innovation Award for Development of Integrated Metabolomics Systems 3US Oncology Pharmaceutical Distribution Service Wins National Safety Council Award 2
...Dillione is president of the health services divis...ld,s largest medical technology companies. She has...of University of Wisconsin Hospitals and Clinics ... in healthcare by Modern Healthcare magazine. ,...view with Dillione. , , WTN: With respec...
... first indication of how they view the Viasys Hea...l Health say they are excited about the growth po... part of a merger agreement between Cardinal Healt...uire Viasys, parent of the NeuroCare Group, for $1...boards of directors. , ,In a conference call with...
... survived two rounds of judging, 26 entries from 1...f the fourth annual Wisconsin Governor,s Business...nding from a pool of nearly 300 entries statewide,... strengths, according Mark Bugher, chairman of the...ng plans include ideas for products or services in...
...rms is writing a series of articles on raising cap...s installment focuses on the Private Placement Mem...a. , , We are frequently asked whether it is nec... referred to as a PPM or an offering memorandum) w...vate placement. Once we tell them yes, it,s genera...
Other Biology Technology:Siemens health services president calls IT benefits unassailable 2Siemens health services president calls IT benefits unassailable 3Siemens health services president calls IT benefits unassailable 4Siemens health services president calls IT benefits unassailable 5Cardinal Health likes growth potential of Viasys NeuroCare Group 2Cardinal Health likes growth potential of Viasys NeuroCare Group 3Business plan finalists capture technology 2When raising capital, why use a Private Placement Memorandum? 2When raising capital, why use a Private Placement Memorandum? 3When raising capital, why use a Private Placement Memorandum? 4When raising capital, why use a Private Placement Memorandum? 5